Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL18603281 | 0.97 | ALDH1A1 (0.45) | ALDH1A1SMN1; SMN2TSHRLMNAMEN1 | |
| Bromide SCHEMBL28355058 | 0.97 | ALDH1A1 (0.45) | ALDH1A1SMN1; SMN2TSHRLMNAMEN1 | |
| Ethylene Glycol SCHEMBL3791681 | 0.91 | ALDH1A1 (0.50) | ALDH1A1SMN1; SMN2TSHRLMNAMEN1 | |
| SCHEMBL3398238 | 0.89 | LMNA (0.52) | ALDH1A1SMN1; SMN2TSHRLMNAMEN1 | |
| SCHEMBL3398750 | 0.89 | LMNA (0.52) | ALDH1A1SMN1; SMN2TSHRLMNAMEN1 | |
| SCHEMBL3398620 | 0.89 | LMNA (0.52) | ALDH1A1SMN1; SMN2TSHRLMNAMEN1 | |
| SCHEMBL3856304 | 0.89 | LMNA (0.52) | ALDH1A1SMN1; SMN2TSHRLMNAMEN1 | |
| SCHEMBL2760769 | 0.89 | LMNA (0.52) | ALDH1A1SMN1; SMN2TSHRLMNAMEN1 | |
| SCHEMBL25760 | 0.88 | ALDH1A1 (0.56) | ALDH1A1SMN1; SMN2TSHRLMNAMEN1 | |
| SCHEMBL24419962 | 0.86 | SMN1; SMN2 (0.58) | ALDH1A1SMN1; SMN2TSHRLMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112452107-B | Method for absorbing carbon monoxide through reaction of ionic liquid/cuprous chloride/alcohol system | 浙江工业大学 | 2022-07-22 | — | — | CN | claimed |
| CN-112452107-A | Method for absorbing carbon monoxide through reaction of ionic liquid/cuprous chloride/alcohol system | 浙江工业大学 | 2021-03-09 | — | — | CN | claimed |
| US-5449709-A | Antistatic | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1995-09-12 | — | — | US | claimed |
| CN-112452107-B | Method for absorbing carbon monoxide through reaction of ionic liquid/cuprous chloride/alcohol system | 浙江工业大学 | 2022-07-22 | — | — | CN | disclosed |
| US-20220145107-A1 | FLAME-RESISTANT PRINT MEDIA COATINGS | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2022-05-12 | — | — | US | disclosed |
| US-20220145112-A1 | FLAME-RESISTANT PRINT MEDIA COATINGS | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2022-05-12 | — | — | US | disclosed |
| US-20220056005-A9 | PROCESS FOR PREPARING CARBONATES BY ADDITION OF CO2 WITH AN EPOXIDE | EVONIK OPERATIONS GMBH (DE) | 2022-02-24 | — | — | US | disclosed |
| US-20210163439-A1 | PROCESS FOR PREPARING CARBONATES BY ADDITION OF CO2 WITH AN EPOXIDE | EVONIK OPERATIONS GMBH (DE) | 2021-06-03 | — | — | US | disclosed |
| WO-2021076145-A1 | MULTI-FUNCTIONAL POLYURETHANE COATINGS | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2021-04-22 | — | — | WO | disclosed |
| EP-3802509-A1 | PROCESS FOR PREPARING CARBONATES BY ADDITION OF CO2 WITH AN EPOXIDE | Evonik Operations GmbH (DE) | 2021-04-14 | — | — | EP | disclosed |
| CN-112452107-A | Method for absorbing carbon monoxide through reaction of ionic liquid/cuprous chloride/alcohol system | 浙江工业大学 | 2021-03-09 | — | — | CN | disclosed |
| US-20070075298-A1 | Biasable transfer composition and member | EASTMAN KODAK COMPANY | 2007-04-05 | — | — | US | disclosed |
| US-6284823-B1 | PHOSPHONIUM SULFONATE; LITHIUM ALKYLBENZENESULFONATE; STEARIC ACID MONOGLYCERIDE OR HARDENED CASTER OIL OR ETHYLENEBISSTEARAMIDE. | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2001-09-04 | — | — | US | disclosed |
| EP-0733473-B1 | Multi-layered film | TEIJIN LTD (JP) | 2000-09-27 | — | — | EP | disclosed |
| US-5879813-A | POLYOLEFIN LAYER, POLYESTER OR POLYPHENYLENE SULFIDE LAYER, QUATERNARY PHOSPHONIUM SALT OF SULFONIC ACID; UNIFORMITY, EASILY PEELED FILM | TEIJIN LIMITED (JP) | 1999-03-09 | — | — | US | disclosed |
| EP-0733473-A2 | Multi-layered film | TEIJIN LIMITED (JP) | 1996-09-25 | — | — | EP | disclosed |
| EP-0403664-B1 | AROMATIC POLYESTER FILM AND PRODUCTION THEREOF | TEIJIN LTD (JP) | 1996-05-01 | — | — | EP | disclosed |
| US-5449709-A | Antistatic | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 1995-09-12 | — | — | US | disclosed |
| US-5188774-A | Extrusion, adhesion on the surface of rotating cooling drum and cooling | TEIJIN LIMITED (JP) | 1993-02-23 | — | — | US | disclosed |
| EP-0403664-A1 | AROMATIC POLYESTER FILM AND PRODUCTION THEREOF | TEIJIN LIMITED (JP) | 1990-12-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220056005-A9 | PROCESS FOR PREPARING CARBONATES BY ADDITION OF CO2 WITH AN EPOXIDE | OSTC, CA4, VKORC1 | ALDH1A1 3691/4885SMN1; SMN2 4695/4885TSHR 4860/4885 |
| US-20210163439-A1 | PROCESS FOR PREPARING CARBONATES BY ADDITION OF CO2 WITH AN EPOXIDE | OSTC, CA4, VKORC1 | ALDH1A1 3691/4885SMN1; SMN2 4695/4885TSHR 4860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.